|
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies |
|
|
|
Title: |
A First-in-Human Phase I Study of LOXO-338, an Oral Selective Bcl-2 Inhibitor, in Patients With Advanced Hematologic Malignancies |
Author: |
Kwiatek, Michal Murthy, Guru Subramanian Guru Hoffmann, Marc Tessoulin, Benoit Danilov, Alexey Alencar, Alvaro J. Shah, Nirav N. Ghesquieres, Hervé Le Gouill, Steven Jurczak, Wojciech Han, Hongmei Yuen, Eunice Patel, Vishalkumar Guo-Avrutin, Yingying Pauff, James M. Roeker, Lindsey E. |
Appeared in: |
Clinical lymphoma myeloma and leukemia |
Paging: |
Volume 25 () nr. 7 pages 512-519 |
Year: |
2025 |
Contents: |
|
Publisher: |
Elsevier Inc. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|